ctDNA as a biomarker of progression in oesophageal adenocarcinoma
Authors:
Open Access
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- National Health and Medical Research Council (1109048, 1139071)
- PA Research Foundation (RSS_2020_040)
- Metro South Hospital and Health Service
- Australian Government (EGAD00001008554, EGAS00001002864)
- Roche Diagnostics USA
This publication has 42 references indexed in Scilit:
- Genome‐wide analysis of esophageal adenocarcinoma yields specific copy number aberrations that correlate with prognosisGenes, Chromosomes and Cancer, 2014
- Somatic Point Mutation Calling in Low Cellularity TumorsPLOS ONE, 2013
- The Cancer Genome Atlas Pan-Cancer analysis projectNature Genetics, 2013
- The causes and consequences of genetic heterogeneity in cancer evolutionNature, 2013
- Signatures of mutational processes in human cancerNature, 2013
- Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexityNature Genetics, 2013
- qpure: A Tool to Estimate Tumor Cellularity from Genome-Wide Single-Nucleotide Polymorphism ProfilesPLOS ONE, 2012
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion SequencingNew England Journal of Medicine, 2012
- The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing dataGenome Research, 2010
- The Sequence Alignment/Map format and SAMtoolsBioinformatics, 2009